KFAS
TXG icon

Keating Financial Advisory Services’s 10x Genomics TXG Stock Holding History

Keating Financial Advisory Services’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Hold
312
– – ﹤0.01% 1181
2026
Q1 		$6.62K Buy
312
+293
+1,542% +$5.86K ﹤0.01% 1295
2025
Q4 		$310 Buy
+19
New +$287 ﹤0.01% 2016

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Keating Financial Advisory Services's TXG Position: Q2 2026 in Review

Keating Financial Advisory Services held its 10x Genomics (TXG) position steady in Q2 2026 at 312 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1181.

Keating Financial Advisory Services first reported a position in TXG in Q4 2025 and has held it in 3 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Keating Financial Advisory Services held 312 shares of 10x Genomics worth $12K as of Q2 2026.
  • Keating Financial Advisory Services left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1181 holding.
  • Keating Financial Advisory Services first reported a position in 10x Genomics in Q4 2025 and has held it in 3 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.